Arkolith/Insider Trading/CRBU/Form 4

Haurwitz Rachel E.

President and CEO, DirectorCaribou Biosciences, Inc. (CRBU) · full profile →Form 4 · filed Mar 17, 2025
Net Buying
Open-Market Buys
$20K
Open-Market Sells
$0
Net Open-Market Flow
$20K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 14, 2025Buy(P)20K$1.02$20K3.4M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001670579-25-000008) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML